Status:

RECRUITING

Hemoglobin Testing in Pregnant Patients

Lead Sponsor:

George Washington University

Collaborating Sponsors:

Inova Health Care Services

Conditions:

Post Partum Hemorrhage

Anemia of Pregnancy

Eligibility:

FEMALE

18-50 years

Brief Summary

The project is a prospective observational study aimed to assess and to validate the use of point-of-care hemoglobin testing in pregnancy. Point-of-care hemoglobin testing has the potential to (1) inc...

Detailed Description

This will be a prospective, observational study for which aim to recruit 200 patients over the study period. Patients will be approached at one of the MFA Obstetrics and Gynecology clinics. Once conse...

Eligibility Criteria

Inclusion

  • Pregnant women ages 18-50 years old

Exclusion

  • Patients with hemoglobinopathies (qualitative defects, sickle-cell anemia) and hemoglobin synthesis disorders (quantitative defects such as thalassemia)
  • Patients with peripheral vascular diseases and skin conditions that affect blood vessels in the digit
  • Patients with hyperbilirubinemia

Key Trial Info

Start Date :

December 3 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2026

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT05977686

Start Date

December 3 2025

End Date

December 1 2026

Last Update

December 10 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

George Washington University

Washington D.C., District of Columbia, United States, 20037

2

Inova Health System

Falls Church, Virginia, United States, 22042